# Ubix Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ubix-therapeutics

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.ubixtrx.com/
- Total disclosed funding: $27M
- Latest round: Series C (Jul 11, 2023)
- Investors on record: 12

## About

Founded in 2018 and based in Seoul, South Korea, Ubix Therapeutics is a pharmaceutical research and development company specializing in the technology known as Proteolysis Targeting Chimera (PROTAC), which is an inhibitor cell technology to treat cancer and intractable disease. In March 2023, Ubix Therapeutics raised KRW 12 billion in series C funding from new investors Scale Up Partners, QUAD Ventures, Medytox Venture Investment, GeneN Investment Partners, and BNH Investment. Returning investors UTC Investment, Mirae Asset Venture Investment, and Atinum Investment also participated in this round. As of 2023, the company is led by its CEO Bo-Kwang Seo.

The company offers research and development of new drug services.

## Funding rounds

- Series C, Jul 11, 2023, $11M — Atinum Investment, UTC Investment, Mirae Asset Venture Investment, BNH Investment, QUAD Ventures, Medytox Venture Investment, Scale Up Partners, GeneN Investment Partners
- Series B, Apr 10, 2020, $12M — Korea Development Bank, KB Investment, Atinum Investment, Partners Investment, UTC Investment, Premier Partners
- Series A, Feb 21, 2019, $3.6M — Mirae Asset Venture Investment, Premier Partners

## Investors

- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series A, Series C
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series A, Series B
- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series B
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series B
- Atinum Investment (https://capitalatlas.ai/funds/atinum-investment) — Series B, Series C
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series B
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series B, Series C
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series C
- QUAD Ventures (https://capitalatlas.ai/funds/quad-ventures) — Series C
- Medytox Venture Investment (https://capitalatlas.ai/funds/medytox-venture-investment) — Series C
- Scale Up Partners (https://capitalatlas.ai/funds/scale-up-partners) — Series C
- GeneN Investment Partners (https://capitalatlas.ai/funds/genen-investment-partners) — Series C